Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model
- 28 November 2015
- journal article
- research article
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 113 (6) , 1357-1368
Abstract
Intraocular pressure (IOP) is mostly regulated by aqueous humor outflow through the human trabecular meshwork (HTM) and represents the only modifiable risk factor of glaucoma. The lack of IOP‐modulating therapeutics that targets HTM underscores the need of engineering HTM for understanding the outflow physiology and glaucoma pathology in vitro. Using a 3D HTM model that allows for regulation of outflow in response to a pharmacologic steroid, a fibrotic state has been induced resembling that of glaucomatous HTM. This disease model exhibits HTM marker expression, ECM overproduction, impaired HTM cell phagocytic activity and outflow resistance, which represent characteristics found in steroid‐induced glaucoma. In particular, steroid‐induced ECM alterations in the glaucomatous model can be modified by a ROCK inhibitor. Altogether, this work presents a novel in vitro disease model that allows for physiological and pathological studies pertaining to regulating outflow, leading to improved understanding of steroid‐induced glaucoma and accelerated discovery of new therapeutic targets. Biotechnol. Bioeng. 2016;113: 1357–1368.Keywords
Funding Information
- National Institutes of Health (R01 EY20670, R01 EY025543)
This publication has 62 references indexed in Scilit:
- Involvement of RhoA/Rho-Associated Kinase Signal Transduction Pathway in Dexamethasone-Induced Alterations in Aqueous OutflowInvestigative Ophthalmology & Visual Science, 2012
- Treatment of Sheep Steroid–Induced Ocular Hypertension with a Glucocorticoid-Inducible MMP1 Gene Therapy VirusInvestigative Ophthalmology & Visual Science, 2010
- Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK–ERK linkageOncogene, 2009
- Prostaglandins Increase Trabecular Meshwork Outflow Facility in Cultured Human Anterior SegmentsAmerican Journal of Ophthalmology, 2008
- Influence of Actin Cytoskeletal Integrity on Matrix Metalloproteinase-2 Activation in Cultured Human Trabecular Meshwork CellsInvestigative Ophthalmology & Visual Science, 2007
- Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor βExperimental Eye Research, 2007
- Fibronectin Matrix Assembly Requires Distinct Contributions from Rho Kinases I and -IIMolecular Biology of the Cell, 2007
- Dexamethasone alters F‐actin architecture and promotes cross‐linked actin network formation in human trabecular meshwork tissueCell Motility, 2004
- Clinical Case NotesClinical & Experimental Ophthalmology, 2004
- Trabecular Meshwork Phagocytosis in Glaucomatous EyesOphthalmologica, 1997